S. 1095 119th Congress Senate

Stop STALLING Act

Official title: A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic d… Show full official titleShow less

Official title: A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.

Introduced: March 24, 2025 Introduced by: Amy Klobuchar Democratic · Minnesota See on congress.gov

Health Administrative remediesBusiness ethicsCivil actions and liabilityCompetition and antitrust

More subjectsShow fewer subjects

Department of Health and Human ServicesDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Licensing and registrationsPrescription drugsPublic participation and lobbying

Everywhere this bill has been 5 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Apr 10, 2025

Placed on Senate Legislative Calendar under General Orders. Calendar No. 45.

Apr 10, 2025

Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

Apr 3, 2025

Committee on the Judiciary. Ordered to be reported without amendment favorably.

Mar 24, 2025

Read twice and referred to the Committee on the Judiciary.

Mar 24, 2025

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now April 10, 2025

Placed on Senate Legislative Calendar under General Orders. Calendar No. 45.

Plain-English summary Congressional Research Service

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act

This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.

The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit is subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.

Hearings & markups 1

Business meeting to consider S.527, to require the Federal Trade Commission to study the role of intermediaries in the …
Meeting Apr 3, 2025 · 10:15 AM EDT · Judiciary Committee

Bill text 2 versions

Introduced in Senate Formatted Text PDF Formatted XML
Reported to Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 1

Judiciary Committee
Senate

Lobbying activity 127

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

BCBSM, INC.
for BCBSM INC · Minnesota · 3rd Quarter 2026 (July 1 - Sep 30)
PUBLIC CITIZEN
for PUBLIC CITIZEN · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
BIOTECHNOLOGY INNOVATION ORGANIZATION
for BIOTECHNOLOGY INNOVATION ORGANIZATION · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
RADIUS ADVOCACY, LLC
for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.
for BLUE CROSS AND BLUE SHIELD OF KANSAS INC · Kansas · 3rd Quarter 2026 (July 1 - Sep 30)
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)

Bodies those filers lobbied

SENATE
125 filings
HOUSE OF REPRESENTATIVES
124 filings
Centers For Medicare and Medicaid Services (CMS)
79 filings
Health & Human Services, Dept of (HHS)
79 filings
White House Office
44 filings
Executive Office of the President (EOP)
43 filings
Office of Management & Budget (OMB)
42 filings
Labor, Dept of (DOL)
34 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 127 filings →

Cosponsors 6